Testing effectiveness (Phase 2)Looking for participantsNCT05350215What this trial is testingAtomoxetine and DAW2022 on OSA SeverityWho this might be right forObstructive Sleep Apnea Brigham and Women's Hospital 18
Not applicableStudy completedNCT04132557What this trial is testingA Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or LisdexamfetamineWho this might be right forAttention Deficit Disorder With Hyperactivity Janssen Research & Development, LLC 430,000
Post-approval studies (Phase 4)Study completedNCT00190931What this trial is testingA Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity DisorderWho this might be right forAttention Deficit Disorder With Hyperactivity Eli Lilly and Company 400
Post-approval studies (Phase 4)Study completedNCT00585910What this trial is testingStudy of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHDWho this might be right forADHDAttention Deficit Hyperactivity Disorder Massachusetts General Hospital 94
Large-scale testing (Phase 3)Study completedNCT00320528What this trial is testingEfficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)Who this might be right forAttention Deficit Disorder With Hyperactivity Eli Lilly and Company 269
Post-approval studies (Phase 4)UnknownNCT03781765What this trial is testingStimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD RiskWho this might be right forADHDAttention Deficit Hyperactivity Disorder Icahn School of Medicine at Mount Sinai 44
Post-approval studies (Phase 4)Study completedNCT00181766What this trial is testingStrattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)Who this might be right forADHD NOS Massachusetts General Hospital 45
Large-scale testing (Phase 3)Study completedNCT00191737What this trial is testingAn Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity DisorderWho this might be right forAttention Deficit Hyperactivity Disorder Eli Lilly and Company 147
Testing effectiveness (Phase 2)Study completedNCT00485628What this trial is testingSafety Study in Outpatient Japanese Children With ADHDWho this might be right forAttention Deficit Hyperactivity Disorder Eli Lilly and Company 37
Large-scale testing (Phase 3)Study completedNCT00498173What this trial is testingEffectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With AutismWho this might be right forAutism Massachusetts General Hospital 60
Large-scale testing (Phase 3)Study completedNCT00486083What this trial is testingComparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHDWho this might be right forAttention Deficit Hyperactivity Disorder Eli Lilly and Company 330
Testing effectiveness (Phase 2)Study completedNCT00607568What this trial is testingAtomoxetine Effects in HumansWho this might be right forPhysiological Stress Yale University 10
Large-scale testing (Phase 3)Study completedNCT01106430What this trial is testingComparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to MethylphenidateWho this might be right forAttention-Deficit/Hyperactivity Disorder Shire 267
Not applicableLooking for participantsNCT07239791What this trial is testingRole of the Noradrenergic System in the Regulation of Learning Dynamics: Evaluation of the Effect of a Low-dose Selective Noradrenaline Reuptake Inhibitor (NOISYXETINE)Who this might be right forRole of the Noradrenergic System in the Regulation of Learning DynamicsNo Disease or Condition is Being Studied Centre Hospitalier St Anne 160
Very early researchStudy completedNCT02879136What this trial is testingTAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's DiseaseWho this might be right forParkinson's Disease, Idiopathic Hubert Fernandez 23
Testing effectiveness (Phase 2)Study completedNCT05101122What this trial is testingStudy for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)Who this might be right forObstructive Sleep Apnea Apnimed 15
Large-scale testing (Phase 3)Study completedNCT05813275What this trial is testingParallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)Who this might be right forOSA Apnimed 646
Post-approval studies (Phase 4)Study completedNCT01065259What this trial is testingConcerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) ChildrenWho this might be right forAttention Deficit Hyperactivity Disorder Peking University 262
Testing effectiveness (Phase 2)Study completedNCT01738191What this trial is testingAtomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)Who this might be right forParkinson's DiseaseCognitive Impairment Medical University of South Carolina 30
Early research (Phase 1)Study completedNCT01177943What this trial is testingA Bioequivalence (BE) Study in Healthy SubjectsWho this might be right forAttention Deficit Hyperactivity Disorder Eli Lilly and Company 42